D I G I T A L D I A G N O S T I C S
second opinions and telepathology. The requirement for high-throughput pathology services becomes even stronger when centralised laboratories need to serve extensive populations.
Innovations in Whole Slide Imaging( WSI) technology combined with AI integration are driving major changes in digital pathology:
Progress in imaging technology alongside improvements in data storage and AI development is revolutionising digital pathology. The development of Whole Slide Imaging( WSI) now enables the capture of ultra-highresolution images which can be stored and distributed with very little delay. After digitisation these images become suitable for AI analysis which helps detect patterns and anomalies while classifying tissue types with greater consistency than manual examination.
Diagnostic workflows now frequently utilise AI-powered tools to help pathologists identify diseases at early stages while simultaneously quantifying biomarkers and standardising interpretations. The algorithms designed for breast and prostate cancer detection improve diagnostic efficiency and minimise inter-observer variability by highlighting suspicious regions and providing grading suggestions. Real-time slide sharing capabilities of cloud-based platforms allow institutions to collaborate on diagnostics without being limited by geographic distances. This technological progress improves diagnostic speed and accuracy while shortening turnaround time which is essential for treating life-threatening conditions.
Growing adoption of telepathology and remote consultations:
The pandemic hastened digital health technology implementation with digital pathology becoming another beneficiary of this trend. Telepathology has become an essential diagnostic tool due to increasing demands for remote consultations and second opinions. Digital platforms now enable hospitals and laboratories to share slides across regions and countries with specialists which allows for expert reviews and collaborations to occur promptly without needing to transport specimens physically.
Telepathy is emerging as a critical solution to the worldwide inequality in pathology services. Rural regions and areas with limited resources experience a significant lack of trained pathologists. Through digital pathology centralised specialists review cases from distant locations which closes existing healthcare gaps to advance healthcare equity. Digital pathology platforms provide educational institutions with benefits for training and research because students and researchers can access actual slides from any location at any time.
Geographical insights:
The North American market achieved a 40.7 % share of the global market in 2023 because government-backed initiatives advanced pathology technology. The dominance resulted from continuous R & D funding and the growing implementation of digital imaging technologies. Their influence grew stronger in the region because prominent players focused on creating innovative solutions to meet the needs of the local population. Market expansion is propelled by academic research and disease diagnosis needs for digital pathology because institutions aim to use its capabilities to enhance diagnostic accuracy and treatment results.
Between 2024 and 2030 the Asia Pacific region will achieve the highest Compound Annual Growth Rate( CAGR) thanks to increased digitalisation activities combined with medical research investments and the growing use of digital imaging technologies in developing economies. The rising occurrence of cancer cases continues to drive market growth which highlights the necessity for new treatment options that will advance market expansion.
Global digital pathology market segmentation and geographical insights:
Based on Product, the digital pathology market is divided into: Software, Device and Storage System. The device segment dominated the market share in 2023 with 51.72 % and is expected to experience substantial growth over the projected period.
Based on Type, the digital pathology market is divided into: Human Pathology and Veterinary Pathology. The human aspect of digital pathology is playing a pivotal role, accounting for approximately 60.0 % market share in 2023.
Based on Application, the digital pathology market is divided into: Drug Discovery & Development, Academic Research and Disease Diagnosis. The academic research segment led the market share in 2023, accounting for 45.7 % and is expected to continue its dominance from 2024 to 2030 due to ongoing research in cancer therapy development and high adoption rates of digital pathology in various studies.
Based on End Use, the digital pathology market is divided into: Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes. The healthcare sector led the market share in 2023 with a notable presence of 36.7 %.
The digital pathology market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Global digital pathology market recent developments and innovations:
In March 2024: Koninklijke Philips N. V.( Netherlands) formed an expanded partnership with AWS to create secure,
64 www. intelligenthealth. tech